知镜 Cognispect · 医学文献与研究工作台

Association between body composition and recurrence in stage II-III colon cancer: A retrospective cohort study.

Young J, Dolan R, Thompson J, Edwards J, Park JH.
Clinical nutrition ESPEN · 2026-08-26 · PMID 42648596

文献摘要

Introduction Colorectal Cancer (CRC) is a common cause of cancer death and prognostic factors are used to determine management. Patients with advanced disease often become cachectic, losing skeletal muscle mass and density, as well as subcutaneous fat. CT can be used to assess body composition by measuring skeletal muscle area, density and subcutaneous and visceral fat. We hypothesise that evidence of sarcopenia or myosteatosis at diagnosis is associated with an increased risk of cancer recurrence. Methods Patients discussed at the CRC multidisciplinary team meeting between 2015 and 2021 at a single institution were collated prospectively. We retrospectively gathered patient information, tumour characteristics and initial CT staging scans. Patients with stage II-III colon cancer were included. Patients with rectal cancer and those who underwent neoadjuvant therapy were excluded. We analysed CT images at the level of the L3 transverse processes using pre-specified criteria with a machine learning model (Mosamatic) to determine body composition. Pre-defined definitions of sarcopenia and myosteatosis were taken from the literature. The primary outcome assessed was recurrence-free survival (RFS). Results 615 patients with stage II-III colon cancer underwent surgery and 120 developed a recurrence. Skeletal muscle radiation attenuation was lower in patients with recurrence (34.3 HU vs 32.2 HU, p = 0.012) but there was no significant difference in Skeletal Muscle Index (44.2 cm 2 /m 2 vs 42.2 cm 2 /m 2 , p = 0.124). 71.7% of patients who developed recurrence had myosteatosis in comparison to 54.9% in the no recurrence group (p = 0.001). At 1-year the RFS was 92.0% (95% CI, 88.7-95.4) in the normal group and 88.3% (95% CI, 84.9-91.7) for those with myosteatosis; but at 5-years the RFS was 86.2% (95% CI, 82.0-90.6) in the normal group and 74.6% (95% CI, 70.0-79.4) in the myosteatosis group (p Conclusion Myosteatosis was associated with increased risk of recurrence in our cohort. This could be a useful prognostic factor in colon cancer and should be validated in prospective studies.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。